Myasthenia gravis (MG) is a neurological disease that can lead to impaired speech, blurred vision, difficulty swallowing, and other symptoms. New research using artificial intelligence and smartphone technology could help speed up diagnosis and predict symptom flares faster in the future, so that those with the disease can act quickly and get care when it’s most crucial.
Status:
Enrolling now
Commitment:
15 – 35 minutes a week
Compensation:
$250 in Amazon Gift Cards
Personalized symptom/health data visualizations
Location:
Smartphone-based at-home trial for U.S. residents.
Length:
3 months
This at-home digital health trial for myasthenia gravis will assess participant-driven data collection using smartphone modules to characterize myasthenia gravis symptoms and develop an A.I. model to predict flares.
If you've been diagnosed with MG and have a smartphone, we invite you to take a quick survey to see if you’re eligible to participate in this trial. Note that the entire trial is conducted from your own phone.
.png)
“New research using artificial intelligence and smartphone technology could help identify patterns and predict symptom flares in individuals suffering from myasthenia gravis. This could mean that people can get treatment faster, minimizing the impact of MG on their daily lives.”
Must have a documented diagnosis of myasthenia gravis
Must have ocular (eye drooping) and/or bulbar (speech) symptoms
Must be over the age of 18
Must reside in the U.S. for the duration of the study
Must be able to read, understand and write in English
Must have a smartphone to support the doc.ai app (iOS or Android)
Trial title
A digital health trial that assesses participant-driven data collection using smartphone modules to characterize myasthenia gravis symptoms and develop an A.I. model to predict flares
Participants
100 participants diagnosed with myasthenia gravis
Research sponsor
doc.ai
Funding provided by
UCB Biopharma (SRL)
Principal investigator
Sandra Steyaert, PhD
doc.ai
Medical expert
Yuen So, MD, PhD
Speech pathologist
Sarah Stranberg, Senior Speech-Language Pathologist
Protocol
DOC-005-2020
Instiutional Review Board
Salus IRB
Is this trial right for me?
If you have a smartphone, a diagnosis of MG, and an interest in advancing research, please take the pre-screener to see if you qualify.
Will I have to take any medications?
You won’t be asked to take any medications that you don’t already take.
What version of iOS or Android do I need to have in order to participate?
Require iOS 10 or later, Android 5.1 or later.
What is the time commitment of the trial?
You’ll be expected to spend about 15 - 35 minutes a week between your twice weekly video check-ins and survey responses and your weekly video journal entries for three months.
Who are you recruiting for this trial?
The recruitment tool for this trial was developed for diversity, fairness, and inclusion. We aim to ensure diversity in the demographics of the trial to better understand the health needs of different populations.
.svg)
.svg)
.svg)
.svg)